Was ist gesichert in der interventionellen Therapie der peripheren arteriellen Verschlusskrankheit?Mobilität der Patienten erhaltenRecommended interventions for the treatment of peripheral artery diseaseKeep the patients moving

[1] Abaraogu UO(2018)Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease PLoS ONE 13 e0207456-816

[2] Ezenwankwo EF(2018)2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the Euro

[3] Dall PM(2018)Drug-coated balloon angioplasty for femoropopliteal in-stent restenosis Circ Cardiovasc Interv 11 e007055-1483

[4] Aboyans V(2019)Global vascular guidelines on the management of chronic limb-threatening Ischemia Eur J Vasc Endovasc Surg 58 S1-13

[5] Ricco JB(2016)Durable clinical effectiveness with paclitaxel-eluting Stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial Circulation 133 1472-105

[6] Bartelink MEL(2019)Endovascular treatment for the common femoral artery: is there a challenger to open surgery? J Cardiovasc Surg (Torino) 60 8-170

[7] Cassese S(2018)Comparison of drug-eluting stent with bare-metal stent implantation in femoropopliteal artery disease: a systematic review and meta-analysis Ann Vasc Surg 50 96-4009

[8] Wolf F(2017)Peripheral artery disease: epidemiology and global perspectives Nat Rev Cardiol 14 156-620

[9] Ingwersen M(2013)Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison Int J Cardiol 168 4002-455

[10] Conte MS(2019)Vessel calcification as a risk factor for in-stent restenosis in complex femoropopliteal lesions after Zilver PTX paclitaxel-coated stent placement J Endovasc Ther 26 613-189

[1] Abaraogu UO(2018)Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease PLoS ONE 13 e0207456-816

[2] Ezenwankwo EF(2018)2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the Euro

[3] Dall PM(2018)Drug-coated balloon angioplasty for femoropopliteal in-stent restenosis Circ Cardiovasc Interv 11 e007055-1483

[4] Aboyans V(2019)Global vascular guidelines on the management of chronic limb-threatening Ischemia Eur J Vasc Endovasc Surg 58 S1-13

[5] Ricco JB(2016)Durable clinical effectiveness with paclitaxel-eluting Stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial Circulation 133 1472-105

[6] Bartelink MEL(2019)Endovascular treatment for the common femoral artery: is there a challenger to open surgery? J Cardiovasc Surg (Torino) 60 8-170

[7] Cassese S(2018)Comparison of drug-eluting stent with bare-metal stent implantation in femoropopliteal artery disease: a systematic review and meta-analysis Ann Vasc Surg 50 96-4009

[8] Wolf F(2017)Peripheral artery disease: epidemiology and global perspectives Nat Rev Cardiol 14 156-620

[9] Ingwersen M(2013)Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison Int J Cardiol 168 4002-455

[10] Conte MS(2019)Vessel calcification as a risk factor for in-stent restenosis in complex femoropopliteal lesions after Zilver PTX paclitaxel-coated stent placement J Endovasc Ther 26 613-189